CSL.AX
CSL Ltd
Price:  
132.19 
AUD
Volume:  
779,357.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CSL.AX EV/EBITDA

140.0%
Upside

As of 2026-08-09, the EV/EBITDA ratio of CSL Ltd (CSL.AX) is 15.33. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CSL.AX's latest enterprise value is 77,445.21 mil AUD. CSL.AX's TTM EBITDA according to its financial statements is 5,052.00 mil AUD. Dividing these 2 quantities gives us the above CSL.AX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 24.6x - 40.8x 26.5x
Forward P/E multiples 17.4x - 20.0x 18.5x
Fair Price 249.76 - 580.00 317.27
Upside 88.9% - 338.8% 140.0%
132.19 AUD
Stock Price
317.27 AUD
Fair Price

CSL.AX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-08-07 10.82
2026-08-06 10.83
2026-08-05 10.71
2026-08-04 10.57
2026-08-03 10.31
2026-07-31 10.19
2026-07-30 10.53
2026-07-29 10.52
2026-07-28 9.95
2026-07-27 9.75
2026-07-24 9.61
2026-07-23 9.74
2026-07-22 9.90
2026-07-21 10.06
2026-07-20 10.23
2026-07-17 10.22
2026-07-16 10.19
2026-07-15 10.13
2026-07-14 10.18
2026-07-13 10.11
2026-07-10 10.17
2026-07-09 10.43
2026-07-08 10.28
2026-07-07 10.32
2026-07-06 10.31
2026-07-03 10.13
2026-07-02 9.88
2026-07-01 9.89
2026-06-30 9.65
2026-06-29 9.71
2026-06-26 9.70
2026-06-25 9.87
2026-06-24 9.70
2026-06-23 9.50
2026-06-22 9.48
2026-06-19 9.77
2026-06-18 9.20
2026-06-17 9.12
2026-06-16 9.10
2026-06-15 9.05
2026-06-12 9.19
2026-06-11 9.20
2026-06-10 8.87
2026-06-09 8.64
2026-06-05 8.52
2026-06-04 8.17
2026-06-03 8.16
2026-06-02 8.15
2026-06-01 8.30
2026-05-29 8.45